| Document |
Document Title |
|
WO/2007/019845 |
The invention relates to compositions containing nanoparticles and to uses of said compositions for encapsulating therapeutically active substances in cells by means of nanoparticles with a particular coating. The particles are chemicall...
|
|
WO/2007/016762 |
The present invention relates to compounds which are perylenequinone derivatives, their stereoisomers and atropisomers. These compounds can be particularly useful as photosensitizers or sononsensitizers in photodynamic or sonodynamic the...
|
|
WO/2007/015105 |
Materials and methods are disclosed for producing nanoparticles linked to antibacterial ligands, including antibiotics and/or molecules which bind to bacterial markers, and for the use of the nanoparticles for the treatment of conditions...
|
|
WO/2007/012209 |
The invention relates to a method for production of means for improving the state or function of systems and materials, including biological, natural, or technical systems and is useful for optimisation of states or processes and/or impr...
|
|
WO/2007/010442 |
A system and method for polymeric drug delivery vehicles activated by ultrasound is disclosed herein. The system and method include polymeric particles, partially filled with a gas or a gas precursor, and partially filled with a liquid c...
|
|
WO/2007/011680 |
A method for identifying a molecule that binds an irradiated tumor in a subject and molecules identified thereby. In some embodiments, the method includes the steps of (a) exposing a tumor to ionizing radiation; (b) administering to a su...
|
|
WO/2007/011680 |
A method for identifying a molecule that binds an irradiated tumor in a subject and molecules identified thereby. In some embodiments, the method includes the steps of (a) exposing a tumor to ionizing radiation; (b) administering to a su...
|
|
WO/2007/010442 |
A system and method for polymeric drug delivery vehicles activated by ultrasound is disclosed herein. The system and method include polymeric particles, partially filled with a gas or a gas precursor, and partially filled with a liquid c...
|
|
WO/2007/004045 |
The present invention relates generally to the field of Photodynamic therapy (PDT) and more particularly to the use of a photosensitizing agent for the preparation of a medicament for the treatment or prevention of an inflammation-associ...
|
|
WO/2007/004045 |
The present invention relates generally to the field of Photodynamic therapy (PDT) and more particularly to the use of a photosensitizing agent for the preparation of a medicament for the treatment or prevention of an inflammation-associ...
|
|
WO/2006/138330 |
Methods of treating tissue are disclosed. The methods can include disposing a plurality of particles including a therapeutic agent within tissue of a subject. The plurality of particles can be exposed to energy to release at least some o...
|
|
WO/2006/138330 |
Methods of treating tissue are disclosed. The methods can include disposing a plurality of particles including a therapeutic agent within tissue of a subject. The plurality of particles can be exposed to energy to release at least some o...
|
|
WO/2006/134365 |
A method of providing magnetised particles at a location using particles which can be switched between magnetic and non-magnetic states by exposure to a suitable magnetic field. The method comprises conveying the particles in their non-m...
|
|
WO/2006/131840 |
An ultrasound treatment comprises applying ultrasound at a first energy level (32) to a region of interest (20) in a subject for activating a cavitation nucleation agent during a first portion of a treatment cycle (tl-t2). Ultrasound at ...
|
|
WO/2006/131840 |
An ultrasound treatment comprises applying ultrasound at a first energy level (32) to a region of interest (20) in a subject for activating a cavitation nucleation agent during a first portion of a treatment cycle (tl-t2). Ultrasound at ...
|
|
WO/2006/129080 |
The invention relates to materials for transducing cells with a viral vector and in vitro and in vivo methods for transducing cells using said materials. In particular, the invention provides materials and methods for cell transduction p...
|
|
WO/2006/130826 |
A method and system for providing a terminally sterilized transdermal influenza vaccine delivery device. A microprojection member having a plurality of stratum corneum- piercing microprojections is coated with an influenza vaccine-formul...
|
|
WO/2006/125452 |
The injectable formulation for treatment by hyperthermia comprises a liquid carrier and heat-generating superparamagnetic iron oxide nanoparticles having a mean diameter not greater than 20 nm. Said injectable formulation is able to form...
|
|
WO/2006/126244 |
It is intended to provide liposomes containing a gas enclosed therein which are useful in ultrasonic diagnostics and ultrasonic therapies. A method of producing liposomes containing a gas enclosed therein characterized by comprising fill...
|
|
WO/2006/122136 |
Methods and apparatuses to apply substances to a biological tissue are described. The tissue having an target below a surface is stretched to provide openings in a surface. Stretching forces a material from the target onto the surface. A...
|
|
WO/2006/119211 |
Aminosterol compounds are described that are useful in combination with photodynamic therapy with verteporfin, rostaporfin or other photo-activated compounds for treating ocular disorders. Compositions comprising such aminosterols and ph...
|
|
WO/2006/119284 |
Disclosed herein are compounds, compositions and methods for using such compounds and compositions in the treatment of hyperproliferative conditions, including precancerous and cancerous conditions. In one embodiment, the compounds inclu...
|
|
WO/2006/117399 |
Phthalocyanine derivatives are described having photosensitising characteristics and high solubility in water, useful for photodynamic treatment of bacterial infections, in particular infections generated by Gram-negative bacteria.
|
|
WO/2006/119211 |
Aminosterol compounds are described that are useful in combination with photodynamic therapy with verteporfin, rostaporfin or other photo-activated compounds for treating ocular disorders. Compositions comprising such aminosterols and ph...
|
|
WO/2006/119284 |
Disclosed herein are compounds, compositions and methods for using such compounds and compositions in the treatment of hyperproliferative conditions, including precancerous and cancerous conditions. In one embodiment, the compounds inclu...
|
|
WO/2006/115273 |
The invention provides a method for treating a body fluid for selectively killing a malignant lymphoma cell, a leukemia cell or an activated macrophage contained in the body fluid in vitro, comprising an addition step of adding a compoun...
|
|
WO/2006/111971 |
A method for destroying harmful cells is provided, applicable in treating proliferative diseases. The cells are destroyed by a combined treatment with a chemiluminescent agent and with a ligand-photosensitizer conjugate. The chemilumines...
|
|
WO/2006/112379 |
A novel drug for treating a vascular lesion in the skin or the subcutaneous soft tissue caused by light irradiation which is efficacious in treating a vascular lesion in the deep part of the skin or the subcutaneous soft tissue caused by...
|
|
WO/2006/111971 |
A method for destroying harmful cells is provided, applicable in treating proliferative diseases. The cells are destroyed by a combined treatment with a chemiluminescent agent and with a ligand-photosensitizer conjugate. The chemilumines...
|
|
WO/2006/110176 |
The present invention provides a method for manufacturing a medicament intended for treating tumors or tumor metastases in a patient, characterized in that a therapeutically effective amount of an EGFR kinase inhibitor and ionizing radia...
|
|
WO/2006/110176 |
The present invention provides a method for manufacturing a medicament intended for treating tumors or tumor metastases in a patient, characterized in that a therapeutically effective amount of an EGFR kinase inhibitor and ionizing radia...
|
|
WO/2006/106383 |
The present invention relates to the use of a compound of formula (3) or a salt thereof for the manufacture of a medicament or phototherapeutic agent for the treatment of acne, Aids, viral hepatitis, diabetic retinopathy, infection with ...
|
|
WO/2006/106984 |
Disclosed is a potentiator for radiation therapy which can be used in combination with cancer radiation therapy to increase the radiation dose and can also reduce adverse side effects of the radiation therapy. A potentiator for radiation...
|
|
WO/2006/107598 |
A chemical conjugate for administration to a patient undergoing photodynamic therapy includes a photoactive compound coupled to a leakage reducing agent that is structured to reduce leakage of the photoactive compound from a patient ' s ...
|
|
WO/2006/107598 |
A chemical conjugate for administration to a patient undergoing photodynamic therapy includes a photoactive compound coupled to a leakage reducing agent that is structured to reduce leakage of the photoactive compound from a patient ' s ...
|
|
WO/2006/105507 |
This invention generally relates to Indoloquinone caused tumor radiation therapy sensitization. More specifically, this invention relates to the discovery of indoloquinones as a radiation sensitizer (radiation therapy adjuvant) due to it...
|
|
WO/2006/105507 |
This invention generally relates to Indoloquinone caused tumor radiation therapy sensitization. More specifically, this invention relates to the discovery of indoloquinones as a radiation sensitizer (radiation therapy adjuvant) due to it...
|
|
WO/2006/102471 |
An apparatus and method for administering focused energy to a body using either a single energy applicator or multiple energy applicators to supply heat prior to, concurrently with and/or after delivery of a drug, gene and/or viral vecto...
|
|
WO/2006/102471 |
An apparatus and method for administering focused energy to a body using either a single energy applicator or multiple energy applicators to supply heat prior to, concurrently with and/or after delivery of a drug, gene and/or viral vecto...
|
|
WO/2006/097707 |
Compositions such as skin equivalents and methods for their manufacture. In particular, a method for modulating the tensile strength and/or elastic strength of a composition comprising living cells suspended in a 3-D support matrix, whic...
|
|
WO/2006/095870 |
[PROBLEMS] To provide a novel photosensitizer, methods of cleaving a protein and cleaving a sugar molecule with light irradiation, and a protein-cleaving agent and sugar molecule-cleaving agent for use in these methods. [MEANS FOR SOLVIN...
|
|
WO/2006/095708 |
A porphyrin array comprising, as a constituent unit, bis(imidazolylporphyrin metal complex) linked through an acetylene bond exhibiting a large two-photon absorption cross-section, wherein an imidazolylporphyrin metal complex having a hy...
|
|
WO/2006/093969 |
A particle with a diameter of at most about 3,000 microns has an internal pressure of at least about 1.1 atmospheres at a temperature of less than about 25°C.
|
|
WO/2006/093972 |
Particles and related methods are disclosed. In some embodiments, a method of making particles can include forming a stream of a mixture including first and second materials, exposing the stream to a vibration, and treating the stream to...
|
|
WO/2006/093969 |
A particle with a diameter of at most about 3,000 microns has an internal pressure of at least about 1.1 atmospheres at a temperature of less than about 25°C.
|
|
WO/2006/091666 |
Provided are methods and compositions for treating ocular conditions characterized by the presence of unwanted choroidal neovasculature, for example, neovascular age-related macular degeneration. The selectivity and sensitivity of, for e...
|
|
WO/2006/091666 |
Provided are methods and compositions for treating ocular conditions characterized by the presence of unwanted choroidal neovasculature, for example, neovascular age-related macular degeneration. The selectivity and sensitivity of, for e...
|
|
WO/2006/089007 |
The present invention relates to novel-compositions of therapeutic-polymeric compounds designed as carriers for small molecule therapeutics delivery and pharmaceutical compositions thereof. The small molecule therapeutic is attached to t...
|
|
WO/2006/088476 |
The present invention is directed to low toxicity boronated compounds and methods for their use in the treatment, visualization, and diagnosis of tumors. More specifically, the present invention is directed to low toxicity carborane-cont...
|
|
WO/2006/089007 |
The present invention relates to novel-compositions of therapeutic-polymeric compounds designed as carriers for small molecule therapeutics delivery and pharmaceutical compositions thereof. The small molecule therapeutic is attached to t...
|
